ERBB2 and gastric adenocarcinoma: Additionally, colorectal adenocarcinomas had a decreased ERBB2/HER2 alteration rate of 5.1%, but had a similar percentage (66%) of ERBB2 amplifications as gastric adenocarcinomas [1].